CYGT yields 666666.67% · PFE yields 6.13%● Live data
📍 CYGT pulled ahead of the other in Year 1
Combined, CYGT + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CYGT + PFE for your $10,000?
Cygnus eTransaction Group, Inc. operates as a transaction driven company that processes sales and payments for its customers' wholesale and retail sales, and distribution channels. The company provides ticketing, reservation, and event management solutions on a fee per transaction basis for theme parks, attractions, live entertainment venues, sporting events, and resorts. It offers smart client online sales engines; electronic, print at home, and delivery of tickets to consumers; virtual inventory distribution for third party sales channels; online sales of merchandise, lodging, rentals, ground transportation, shows, and events; self service ticketing systems with electronic will-call; and on-property box office management systems. Cygnus eTransaction Group also provides complimentary products and services, including access control, stored value cards, payment processing, management tools, real-time reporting, and Web analytics. In addition, the company offers a cePay payment processing system that allows its leisure customers and financial processing customers to obtain credit card, debit card, and e-check payment processing through a consolidated payment solution. cePay is implemented utilizing a plug 'n' play virtual terminal or a proprietary application programming interface. Cygnus eTransaction Group is headquartered in Lake Mary, Florida.
Full CYGT Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.